Clinical Trial of Vitamin E to Treat Muscular Cramps in Patients With ALS
NCT00372879 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2016-03-03
Summary
Muscular cramps are a common and uncomfortable symptom of amyotrophic lateral sclerosis (ALS). This clinical trial will compare the response of high dose vitamin E supplementation to placebo for treatment of muscular cramps in patients with ALS. We hypothesize that vitamin E will be more effective than placebo in treating cramps.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Vitamin E
Vitamin E 800IU bid
Sponsors & Collaborators
-
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
lead OTHER
Principal Investigators
-
Michael J Strong, MD, FRCPC · Clinical Neurological Sciences, London Health Sciences Centre
-
Christen L Shoesmith, MD, FRCPC · Clinical Neurological Sciences, London Health Sciences Centre
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-12-31
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- Canada
Study Locations
More Related Trials
-
Study of the Effects Strengthening Exercises in Individuals With ALS
NCT00204464 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers
NCT01039909 ·Status: WITHDRAWN ·Phase: PHASE1
-
Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
NCT04244630 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT00330681 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
NCT01492686 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis
NCT02487407 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Study: Treatment of ALS Fatigue With PolyMVA
NCT04557410 ·Status: COMPLETED ·Phase: PHASE1
-
At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis
NCT07006571 ·Status: RECRUITING ·Phase: NA
-
Rehabilitative Trial With tDCS in Amyotrophic Lateral Sclerosis
NCT03293394 ·Status: COMPLETED ·Phase: NA
-
Expanded Controlled Study of Safety and Efficacy of MCI-186 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00424463 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis (ALS)
NCT00790582 ·Status: COMPLETED ·Phase: PHASE2
-
Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)
NCT00838617 ·Status: COMPLETED
-
Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)
NCT01091142 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]
NCT00005674 ·Status: COMPLETED ·Phase: PHASE2
-
Mexiletine for the Treatment of Muscle Cramps in ALS
NCT01811355 ·Status: COMPLETED ·Phase: PHASE4
-
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
NCT06391645 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00444613 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT01089010 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients
NCT05423678 ·Status: NOT_YET_RECRUITING
-
A First in Human Study of ORT247 in Healthy Volunteers
NCT06769620 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Procedures to Support Research in ALS
NCT03489278 ·Status: RECRUITING
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III
NCT00415519 ·Status: COMPLETED ·Phase: PHASE3
-
Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]
NCT00214110 ·Status: COMPLETED ·Phase: PHASE2
-
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
NCT06665165 ·Status: RECRUITING ·Phase: PHASE1
-
Cortico-Spinal tDCS as Rehabilitative Intervention in Amyotrophic Lateral Sclerosis
NCT04293484 ·Status: COMPLETED ·Phase: NA